

“I’ve been victimised very unfairly and wrongly,” he told the newspaper, adding that he had not boosted capacity earlier because “there were no orders, we did not think we needed to make more than 1billion doses a year”. Serum Institute of India is a manufacturer and supplier of vaccines in India. Poonawalla also defended SII saying that the firm had been criticised by politicians and critics over the vaccine shortages. “Everybody really felt that India had started to turn the tide on the pandemic,” he was quoted as saying. Poonawalla founded Serum Institute of India (SII) which launched its first therapeutic anti-tetanus serum within two years, and began producing the anti-tetanus vaccines. The Financial Report also quoted Poonawalla as saying that Indian authorities did not expect that a second COVID-19 wave would hit the country so hard specially after the decline in coronavirus cases in January. The top court asked the Centre for details about the grants made to Serum Institute of India (SII) and Bharat Biotech.

It is to be noted that the shortage of vaccines is not a good news for India as it has has opened vaccination for everyone above 18 years from May 1. In December Serum Institute released the first vaccine to be fully developed in India, against a variant of pneumonia which kills 68,000 Indian children a year. "Though we enjoy your music very much your views on #vaccines come across as irresponsible and borderline dangerous, considering the influence you have today and may have in the future vaccines save lives," Poonawalla tweeted in July.Amid rising coronavirus COVID-19 cases in India and growing demand for vaccines, Serum Institute of India (SII) chief executive Adar Poonawalla has said the shortage of COVID-19 vaccine would remain till July.Īccording to a Financial Times report, the SII CEO said that production of vaccines would increase in July from about 60-70 million doses a month to about 100 million. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, with its partner, Serum Institute of India Pvt. Unsurprisingly, the father-of-two has not held back from taking so-called anti-vaxxers to task, including berating US rapper Kanye West for spreading conspiracy theories. The pandemic has transformed Poonawalla's public profile, from a jet-setting billionaire known for his expensive taste in cars and fine art to a pharma-tycoon applauded for his willingness to take risks and his commitment to affordable vaccines. is now the worlds largest vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. "We are used to these kinds of pressures because even in the past there were situations when we were required to step up the production to meet individual countries' requirements," Suresh Jadhav, Serum Institute's executive director, told AFP.Įven a deadly fire at an under-construction building this week failed to dent confidence, with Poonawalla promptly tweeting that "there would be no loss of #COVISHIELD production due to multiple production buildings that I had kept in reserve to deal with such contingencies". Related Story Covid-19 shots being delivered across India ahead of 'world's biggest vaccination drive'
